146 related articles for article (PubMed ID: 16396150)
1. Novel agents in first-line therapy for myeloma.
Jagannath S
Oncology (Williston Park); 2005 Nov; 19(12):1551-4. PubMed ID: 16396150
[No Abstract] [Full Text] [Related]
2. Therapy-resistant leg ulcer caused by multiple myeloma.
Bago A; Schweiter J; Kiss M; Furesz J; Vajda A; Balo-Banga JM
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):647-8. PubMed ID: 16164734
[No Abstract] [Full Text] [Related]
3. Two cases of plasma cell leukemia with atypical immunophenotype.
Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
[No Abstract] [Full Text] [Related]
4. Guidelines on the diagnosis and management of multiple myeloma 2005.
Smith A; Wisloff F; Samson D; ; ;
Br J Haematol; 2006 Feb; 132(4):410-51. PubMed ID: 16412016
[No Abstract] [Full Text] [Related]
5. Myeloma bone disease: pathogenesis and treatment.
Roodman GD;
Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
[TBL] [Abstract][Full Text] [Related]
6. [Meningeal plasmacytoma: delayed diagnosis with sequelae].
Buchbender C; Antoch G; Nawatny J
Rofo; 2011 Aug; 183(8):761-2. PubMed ID: 21442568
[No Abstract] [Full Text] [Related]
7. [Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient].
Rekhtina IG; Biriukova LS
Ter Arkh; 2008; 80(7):62-4. PubMed ID: 18763600
[No Abstract] [Full Text] [Related]
8. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
Huston A; Brown J; Roodman GD
Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
[No Abstract] [Full Text] [Related]
9. Amyloid deposition of systemic myeloma-associated amyloidosis excludes actinic elastotic material.
Wada N; Fujimoto N; Komatsu T; Tajima S; Ishibashi A
Eur J Dermatol; 2002; 12(6):607-8. PubMed ID: 12459542
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma in the era of novel agents.
Dimopoulos MA; Attal M
Semin Hematol; 2009 Apr; 46(2):107-9. PubMed ID: 19389493
[No Abstract] [Full Text] [Related]
11. Non-secretory multiple myeloma with hypercalcemic acute renal failure.
Prakash MS; Baliga KV; Singh AP; Mishra DK
J Assoc Physicians India; 2002 Oct; 50():1330-1. PubMed ID: 12568228
[No Abstract] [Full Text] [Related]
12. Multiple myeloma.
Bhattacharya SK; Singh NK; Srivastava PK; Tripathi K; Somani PN
J Indian Med Assoc; 1984 Nov; 82(11):394-7. PubMed ID: 6535796
[No Abstract] [Full Text] [Related]
13. [Multiple myeloma -- case report].
Zettl F; Jung W; Schroers R
Dtsch Med Wochenschr; 2005 Feb; 130(6):277; quiz 287-90. PubMed ID: 15692901
[No Abstract] [Full Text] [Related]
14. Infiltration of the spinal cord in a patient with multiple myeloma.
Varettoni M; Corso A; Zappasodi P; Calliada F; Castagnola C; Mangiacavalli S; Lazzarino M
J Clin Oncol; 2008 Sep; 26(25):4207-9. PubMed ID: 18757337
[No Abstract] [Full Text] [Related]
15. Acute tubulo-interstitiel nephritis associated with diffuse large B-cell lymphoma presenting as acute renal failure.
Dede F; Yilmaz B; Ayli D; Kayataş M; Atilgan G; Caner S; Akyürek N; Odabaş AR
Ren Fail; 2008; 30(4):465-7. PubMed ID: 18569923
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid fistula associated with an empty sella.
Palacios E; Rojas R; Restrepo S
Ear Nose Throat J; 2002 Nov; 81(11):764-5. PubMed ID: 12472026
[No Abstract] [Full Text] [Related]
17. Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas.
Hughes M; Micallef-Eynaud P
Clin Lab Haematol; 2006 Aug; 28(4):267-9. PubMed ID: 16898968
[TBL] [Abstract][Full Text] [Related]
18. Myeloma update.
Mulligan ME
Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Berenson JR; Yang HH; Sadler K; Jarutirasarn SG; Vescio RA; Mapes R; Purner M; Lee SP; Wilson J; Morrison B; Adams J; Schenkein D; Swift R
J Clin Oncol; 2006 Feb; 24(6):937-44. PubMed ID: 16418495
[TBL] [Abstract][Full Text] [Related]
20. Multiple eruptive dermatofibromas and immunosuppression: report of two cases and review of the literature.
Zaccaria E; Rebora A; Rongioletti F
Int J Dermatol; 2008 Jul; 47(7):723-7. PubMed ID: 18613883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]